ClinicalTrials.Veeva

Menu

Prevalence of Metabolic Syndrome in Patients With Schizophrenia in Korea

A

Asan Medical Center

Status

Unknown

Conditions

Schizophrenia
Metabolic Syndrome

Study type

Observational

Funder types

Other

Identifiers

NCT01477918
MetS_1005

Details and patient eligibility

About

The aim of this study is to examine the prevalence of the Metabolic syndrome(MetS) in Korean patients with schizophrenia.

Primary objective:

• To investigate the prevalence of the MetS in Korean patients with schizophrenia

Secondary objectives:

• To compare the prevalence of the MetS among 3 groups according to antipsychotics: typical antipsychotic monotherapy group, atypical antipsychotic monotherapy group, 2 or more antipsychotics group (polypharmacy)

Enrollment

1,000 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Diagnosis of schizophrenia according to DSM-IV-TR
  • Age between 18-65 years

Trial contacts and locations

1

Loading...

Central trial contact

Yeon-Ho Joo, Ph.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems